Protein has become a bit of a battleground in Australia of late; but the economics suggest there’s plenty of room for all players – traditional and alternative.
GOOD Meat, the cell-cultured meat business of US alt-protein startup Eat Just, has secured $97 million in funding as a continuation of the $170 million
Qatar and US-based Eat Just will build what they say is “the MENA region’s first-ever facility for cultivated meat” in the Middle Eastern country.
New Carnivore has made seven deals to date, co-investing with leading VCs such as Andreessen Horowitz, Breakthrough Energy Ventures, and DCVC.
However, the survey’s choice of terminology may be problematic.
The deal “sets an example for a novel way of building and growing a company as part of the accelerating [alt-protein] industry,” said Shiok Meats CEO Sandhya Sriram.
Cell lines for cultivated meat R&D are proving hard to come by. But don’t point the finger of blame at startups, as a major UK newspaper appeared to do this week.
Shiok Meats is planning to open a production facility in its native Singapore by 2023 to cultivate cell-based shrimp, lobster, crab, and crayfish at commercial scale.
As is the case with a lot of great Canadian ideas, the founders of Future Fields came up with theirs while waiting in line at Tim Hortons.
Nestlé is said to be planning a range of products which blend cultivated meat with plant-based protein.
The Israeli company secured the mega-funding from L Catteron and agrifood corporates BRF, Cargill, CJ CheilJedang, and Thai Union.
Eat Just raised $200 million in private funding back in March, with its GOOD Meat cell-culturing unit separately scoring $170 million in May.
CEO Sriram on why she made the leap from full-time scientist to founder – and how she reconciles vegetarianism with being a cultured meat eater.
NTU students will learn the science behind cell-cultured, plant-based, and fermented proteins, as well as the market opportunities and regulatory issues they present.
GOOD Meat secured the funding after its parent company successfully obtained world-first regulatory clearance for a cell-cultured meat product in Singapore.
Sponsored
Sponsored post: The innovator’s dilemma: why agbioscience innovation must focus on the farmer first